re: $$$ letter to shareholders Well hello Arthur . dont know anything about horses pricks , but if they can also cure it in horses asses you should be OK . Will let you know when the trials start .
I would be interested to hear anything you know about those Mesothelioma trials , science , mode of action , company name etc.
As for skin cancer , there is a glossy photo in the glossy handout of a 6cm bulging skin cancer before and another after one injection where it is totally collapsed . So yes it still works on skin cancer .
Also in the glossy handout is a picture of the way it clears up psorisis in a very diluted form of the drug . It took 28 days , but you are sure to know that is how long it takes for the good skin to grow through .
The glossy handout also quotes SBP002s response rate over 68 different tumours as tested by Dr Robert Nagourney of an average of 57% . examples , breast 59% , ovarian 52% , gastric 66% , NSCLC(lung) 75% . Response rates mean at least 75% reduction of tumor and does not include disease stabilization .
You have to remember all the above response rates were achieved on human tumors ex-vivo . It does not take into account the immune system boost that seems to take place as the 002 attacks the tumor .
The brocure also talks about SBPs ability to modulate the cytokine IL-6 . It is known to make people feel unwell and is involved in cancer cell proliferation .
This would make it an ideal candidate to use with other known chemo treatments .
It also opens up use on a wide range of IL-6 related diseases such as rheumatoid arthritis , psoraisis , psoraisitic arthritis , and there are too many more for me to type all the way to cardio myopathy . Patents are lodged for these applications .
The brocure also details tests made so far to use the binding effect to cancer cells a a diagnostic tool where a visualising agent was added to the drug to successfully identify cancer cells .
As there will be about 15000 biotech professionals at the conference and only 3 days , I would think the brocure is good value .
Dont forget the info on the meso trials Arthur . Looking forward to it .
Skint .
- Forums
- ASX - By Stock
- SBP
- letter to shareholders
SBP
solbec pharmaceuticals limited
letter to shareholders, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online